The modifier roles of the PVs or LPVs in the PKP2, DSP, SCN10A, and others identified in the family members benefit from biological plausibility and the well-established roles of these genes in cardiomyopathies and/or arrhythmias[17,18,19]. This evidence concerns the gene SCN10A and cardiomyopathy.